Using computer modeling, researchers from Houston Methodist have found that edelfosine, an FDA-approved investigational leukemia drug, can prevent cancer cells from metastasizing. Their work was published yesterday in Cancer Research. Read more.
- Scientist (Microbiology, Synthetic Biology, Molecular Biology).
- Founder / CEO of the biotech company Peption LLC.
- Passionate about biotechnological innovations to address important global health issues.
View all posts by Dr. Baek